2011 HCM Treatment Guidelines issued by AHA/ACCF

As part of the mission of the HCMA we are in close communication with thought leaders and scientists dedicated to undertanding HCM. At a conference several years ago we asked leaders at AHA to include HCM in the "get with the guidelines" program. This was a huge task requiring input from many sources and took many years to complete but it is finally here. This document contains the latest in the management of HCM, including items from genetics to transplant and all point between. The HCMA is happy to have been a party to the creation of this document. Our sincere thanks to Dr. Robert Bonow and Dr. Rick Nishimura for getting the ball rolling all those years ago in the hall ways of scientific session! Additionally thank you to all members of the writing team - most especially the co-chairs Dr. Barry Maron and Dr. Bernard Gersh for taking on this not always easy task. ... Full story

What is Hypertrophic Cardiomyopathy (HCM)?

To better understand what Hypertrophic Cardiomyopathy, HCM, is lets first talk about how cardiomyopathies are described. Cardiomyopathy is a condition in which the muscle of the... Full story

About the HCMA

The Hypertrophic Cardiomyopathy Association is a not for profit 501(c) (3) organization formed in 1996 to provide information, support and advocacy to patients, their families and medical providers. ... Full story